Yinuokang (Nanjing) Biomedical Co.
Latest round
- Angel
Last raised
- May 2022
Total raised
- $15M
Investors
- 4
About Yinuokang (Nanjing) Biomedical Co.
, Ltd. operates as an anticancer drug developer that focuses on targeted protein degradation field. The founder of this company, Dr. Xavilin, has over 25 years of drug discovery experience, including co-inventing the sensational heavyweight drug celecoxib., Ltd. The company provides anticancer drugs. The company provides focuses on targeted protein degradation drugs and tumour immune drugs R&D. In addition, it also provides pharmaceutical commissioning and drug clinical trial services. The company plans to conduct two IND-enabling phases with "first-in-class" potential in 2024, with the first IND application expected to be formally filed in 2024.
Who invested in Yinuokang (Nanjing) Biomedical Co.
4 investors across 1 round
See all investors in Yinuokang (Nanjing) Biomedical Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
May 13, 2022
Amount
$15M
Investors
Questions about Yinuokang (Nanjing) Biomedical Co.
Who invested in Yinuokang (Nanjing) Biomedical Co.?
Yinuokang (Nanjing) Biomedical Co. has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Yinuokang (Nanjing) Biomedical Co. raised?
Yinuokang (Nanjing) Biomedical Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Yinuokang (Nanjing) Biomedical Co. last raise money?
Yinuokang (Nanjing) Biomedical Co.'s most recent round on record is a Angel, in May 2022.
What does Yinuokang (Nanjing) Biomedical Co. do?
Yinuokang (Nanjing) Biomedical Co. is a pharmaceuticals company.
Where is Yinuokang (Nanjing) Biomedical Co. headquartered?
Yinuokang (Nanjing) Biomedical Co. is headquartered in Nanjing, China.
Which VCs invest in companies like Yinuokang (Nanjing) Biomedical Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back pharmaceuticals companies at Yinuokang (Nanjing) Biomedical Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Angel
Raising like Yinuokang (Nanjing) Biomedical Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.